IPHYF   $2.91  -3.00% Market Closed

INNATE PHARMA
Total Cash 91.80M
totalCashPerShare 1.134
EBITDA -35.96M
Total Debt 35.50M
quickRatio 2.763
currentRatio 2.919
Total Revenue 33.79M
debtToEquity 123.291
Revenue/Share 0.419
ROA -0.13758
ROE -0.78587997
grossProfits
freeCashflow 13.06M
operatingCashflow -18.06M
earningsGrowth
revenueGrowth -0.693
grossMargins -0.58769
ebitdaMargins -1.06425
operatingMargins -2.13147
profitMargins -1.00781
enterpriseValue 125.44M
forwardPE
floatShares 31.56M
sharesOutstanding 80.95M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.25%
heldPercentInstitutions 0.10%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.356
Price To Book help_outline 6.31
earningsQuarterlyGrowth
netIncomeToCommon -34.05M
trailingEps -0.46%
forwardEps
enterpriseToEbitda -3.49
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 11
lastUpdated Nov. 7, 2024, 12:30 a.m.